Abstract
The markers of oxidative stress were measured in four cerebrocortical regions of Alzheimer's disease (AD) and age-matched control brains. In controls the levels of diene conjugates (DC) and lipid peroxides (LOOH) were significantly higher in the sensory postcentral and occipital primary cortex than in the temporal inferior or frontal inferior cortex. The antioxidant capacity (AOC) was highest in the temporal, and GSH in the frontal inferior cortex. The highest activity of superoxide dismutase (SOD) and catalase (CAT) was found in the occipital primary cortex. Compared with controls, significantly higher level of DC and LOOH and attenuated AOC were evident in AD temporal inferior cortex. In AD frontal inferior cortex moderate increase in LOOH was associated with positive correlation between SOD activity and counts of senile plaques. Our data suggest that in AD cerebral cortex, the oxidative stress is expressed in the reducing sequence: temporal inferior cortex > frontal inferior cortex > sensory postcentral cortex ≃ occipital primary cortex, corresponding to the histopathological spreading of AD from the associative to primary cortical areas.
Similar content being viewed by others
REFERENCES
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite M. L., and Neve, R. L. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417–420.
McKee, A. C., Kowall, N. W., Schumacher, J. S., and Beal, M. F. 1998. The neurotoxicity of amyloid beta protein in aged primates. Amyloid 5:1–9.
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M. E., Wu, J. F., Floyd, R. A., and Butterfield, D. A. 1994. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270–3274.
Hensley, K., Butterfield, D. A., Hall, N., Cole, P., Subramaniam, R., Mark, R., Mattson, M. P., Markesbery, W. R., Harris M. E., and Aksenov, M. 1996. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's diseaseassociated beta peptide. Ann. NY Acad. Sci. 786:120–134.
Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C. L., and Beyreuther, K. 1997. Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol. 54: 533–539.
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., and Perry, G. 2000. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502:139–144.
Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., and Beyreuther, K. 1992. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:18210–18217.
Dickson, D. W. 1997. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:321–329.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., and Smith, M. A. 1994. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91:7787–7791.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., and Markesbery, W. R. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88: 10540–10543.
Lovell, M. A., Ehman, W. D., Butler, S. M., and Markersbury, W. R. 1995. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45:1594–1601.
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., and Halliwell, B. 1997. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68:2061–2069.
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., and Freedman, M. L. 1998. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exper. Neurol. 150:40–44.
Famulari, A. L., Marschoff, E. R., Llesuy, A. F., Kohan, S., Serra, J. A., Dominquez, R. O., Repetto, M., Reides, C., and Sacerdote deLustig, E. 1996. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls. J. Neurol. Sci. 141:69–78.
Thome, J., Gsell, W., Rösler, M., Kornhuber, J., Frölich, L., Hashimoto, E., Zielke, B., Wiesbeck, G. A., and Riederer, P. 1997. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. Life Sci. 60:13–19.
Van Hoesen, G. W. 1997. Cortical feedforward and cortical feedback neural systems in Alzheimer's disease. Pages 17–31, in Hyman, B. T., Duyckaerts, C., Christen, Y. (eds.), Connections, Cognition and Alzheimer's Disease, Springer-Verlag, Heidelberg.
Braak, H., Braak, E., Bohl, J., and Bratzke, H. 1998. Evolution of Alzheimer's disease related cortical lesions. J. Neural Transm. Suppl. 54:97–106.
Small, G. W., Mazziotta, J. C., Collins, M. T., Baxter, L. R., Phelps, M. E., Mandelkern, M. A., Kaplan, A., La Rue, A., Adamson, C. F., and Chang, L. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273:942–947.
Butterfield, D. A., Howard, B., Yatin, S., Koppal, T., Drake, J., Hensley, K., Aksenov, M., Aksenova, M., Subramaniam, R., Varadarajan, S., Harris-White, M. E., Pedigo, N. W. Jr., and Carney, J. M. 1999. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci. 65: 1883–1992.
Venarucci, D., Venarucci, V., Vallese, A., Battila, L., Casado, A., De la Torre, R., and Lopez Fernandez, M. E. 1999. Free radicals: important cause of pathologies refer to ageing. Panminerva Med. 41:335–339.
Reed, D. J. 1990. Glutathione: toxicologic implications. Annu. Rev. Pharmacol. Toxicol. 30:603–631.
Schulz, J. B., Lindenau, J., Seyfried, J., and Dichgans, J. 2000. Glutahione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267:4904–4911.
Bannister, J. V., Bannister, W. H., and Rotilio, G. 1987. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit. Rev. Biochem. 22:111–180.
Cochrane, C. G. 1991. Cellular injury by oxidants. Am. J. Med. 91:23S–30S.
Matés, J. M. and Sànchez-Jimenéz, F. 1999. Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 4:D339–345.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task forces on Alzheimer's disease. Neurology, 34:939–944.
Mirra, S. S., Heyman, A., and McKeel, D. 1991. The Consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's Disease. Neurology 41:479–486.
Bogdanovic, N. and Morris, J. C. 1995. Diagnostic criteria for Alzheimer's Disease in Multicentre Brain Banking. Pages 20–29, in Cruz-Sanchez, F. F., Ravid, R., and Cuziner, M. L. (eds.) Neuropathological diagnostic criteria for Brain Banking. Biomedical and Health Research Series, vol. 10, IOS Press, Amsterdam.
Amstrong, D. (ed.) 1998. Free radical and antioxidant protocols. Introduction. Pages v–viii, in Methods in Molecular Biology, vol. 108, Humana Press, New Jersey.
Halliwell, B. and Gutteridge, J. M. C. 1999. Free radicals in biology and medicine. Oxford University Press, Oxford.
Starkopf, J., Zilmer, K., Vihalemm, T., Kullisaar, T., Zilmer, M., and Samarütel J. 1995. Time course study of oxidative stress during open hart surgery. Scand. J. Thor. Cardiovasc. Surg. 29:181–186.
Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351–358.
Ristimäe, T., Zilmer, M., Zilmer, K., Kairane, C., Kullisaar, T., and Teesalu, R. 1999. Effect of low-dose aspirin on the markers of oxidative stress. Cardiovasc. Drugs Ther. 13:485–490.
Bhat, G. B., Tinsley, S. B., Tolson, J. K., Bath, J. M., and Block, E. R. 1992. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury. J. Cell. Physiol. 151:228–238.
Goth, L. 1991. A simple method for the determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 196:143–152.
Lowry, O. H., Rosenburg, N. L., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Fröhlich, L. and Riederer, P. 1995. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforsch. 45:443–446.
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., and Perry, G. 2000. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502:139–144.
Cummings, J. L. 2000. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol. Aging 21:845–861.
Perry, G., Raina, A. K., Nunomura, A., Wataya, T., Sayre, L. M., and Smith, M. A. 2000. How important is oxidative damage? Lessons from Alzheimer's disease. Free Rad. Biol. Med. 28:831–834.
Smith, M. A., Rudnicka-Nawrot, M., Richey, P. L., Praprotnik, D., Mulvihill, P., Miller, C. A., Sayre, L. M., and Perry, G. 1995. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64:2660–2666.
Geddes, J. W., Wilson, M. C., Miller, F. D., and Cotman, C. W. 1990. Molecular markers of reactive plasticity. Adv. Exp. Med. Biol. 268:425–432.
Papolla, M. A., Sos, M., Omar, R. A., and Sambamurti, K. 1996. The heat shock/oxidative stress connection. Relevance to Alzheimer disease. Mol. Chem. Neuropathol. 28:21–34.
Hoff, P. R., Cox, K., and Morrison, J. H. 1990. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301:44–54.
Yoo, B. C., Seidl, R., Cairns, N., and Lubec, G. 1999. Heatshock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease. J. Neural. transm. Suppl. 57: 315–322.
Rehfeld, J. F. and Nielsen, F. C. 1995. Molecular forms and regional distribution of cholecytokinin in the central nervous system. Pages 33–56, in Bradwejn, J. and Vasar, E. (eds.), Neuroscience Intelligence Unit. Cholecytokinin and anxiety: from neuron to behaviour. R.G. Landes Company, Austin.
Palmer, A. M. and Burns, M. A. 1994. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res., 645:338–342.
McIntosh, L. J., Trush, M. A., and Troncoso, J. C. 1997. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Rad. Biol. Med. 23:183–190.
Markesbery, W. R. 1999. The role of oxidative stress in Alzheimer's disease. Arch. Neurol. 56:1449–1452.
Schulz, J. B., Lindenau, J., Seyfried, J., and Dichgans, J. 2000. Glutahione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267:4904–4911.
Kang, Y., Wiswanath, V., Jha, N., Qiao, X., Mo, J. Q., and Andersen, J. K. 1999. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional-specific enzyme activities and glutathione levels. J. Neurosci. Res. 58: 436–441.
Chen, L., Richardson, J. S., Caldwell, J. E., and Ang, L. C. 1994. Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int. J. Neurosci. 75:83–90.
Furuta, A., Price, D. L., Pardo, C. A., Troncoso, J. C., Xu, Z.-S., Taniguchi, N., and Martin, L. J. 1995. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex. Am. J. Pathol. 146:357–367.
Smith, M. A., Sayre, L. M., Monnier, V. M., and Perry, G. 1996. Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles. Mol. Chem. Neuropathol. 28:41–48.
Behl, C. 1999. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 57: 301–323.
Albers, D. S. and Beal, M. F. 2000. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative diseases. J. Neural. Transm. Suppl. 59:133–154.
Duyckaerts, C., Colle, M. A., Dessi, F., Piette, F., and Hauw, J. J. 1998. Progression of Alzheimer histopathological changes. Acta Neurol. Belg. 98:180–185.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karelson, E., Bogdanovic, N., Garlind, A. et al. The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense. Neurochem Res 26, 353–361 (2001). https://doi.org/10.1023/A:1010942929678
Issue Date:
DOI: https://doi.org/10.1023/A:1010942929678